ARHGEF28
Rho guanine nucleotide exchange factor 28
Also known as: ARG28_HUMAN, p190RhoGEF, RGNEF, RIP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N1W1
- Gene
- ARHGEF28
- Ensembl
- ENSG00000214944
- Chromosome
- 5
- Canonical length
- 1705 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Microtubules,Cytosol
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
This gene encodes a member of the Rho guanine nucleotide exchange factor family. The encoded protein interacts with low molecular weight neurofilament mRNA and may be involved in the formation of amyotrophic lateral sclerosis neurofilament aggregates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
Canonical amino-acid sequenceUniProt
1705 residues, UniProt reviewed canonical sequence.
>Q8N1W1|ARHGEF28
1 MELSCSEAPL YGQMMIYAKF DKNVYLPEDA EFYFTYDGSH QRHVMIAERI EDNVLQSSVP
61 GHGLQETVTV SVCLCSEGYS PVTMGSGSVT YVDNMACRLA RLLVTQANRL TACSHQTLLT
121 PFALTAGALP ALDEELVLAL THLELPLEWT VLGSSSLEVS SHRESLLHLA MRWGLAKLSQ
181 FFLCLPGGVQ ALALPNEEGA TPLDLALREG HSKLVEDVTN FQGRWSPSFS RVQLSEEASL
241 HYIHSSETLT LTLNHTAEHL LEADIKLFRK YFWDRAFLVK AFEPEARPEE RTAMPSSGAE
301 TEEEIKNSVS SRSAAEKEDI KRVKSLVVQH NEHEDQHSLD LDRSFDILKK SKPPSTLLAA
361 GRLSDMLNGG DEVYANCMVI DQVGDLDISY INIEGITATT SPESRGCTLW PQSSKHTLPT
421 ETSPSVYPLS ENVEGTAHTE AQQSFMSPSS SCASNLNLSF GWHGFEKEQS HLKKRSSSLD
481 ALDADSEGEG HSEPSHICYT PGSQSSSRTG IPSGDELDSF ETNTEPDFNI SRAESLPLSS
541 NLQSKESLLS GVRSRSYSCS SPKISLGKTR LVRELTVCSS SEEQRAYSLS EPPRENRIQE
601 EEWDKYIIPA KSESEKYKVS RTFSFLMNRM TSPRNKSKTK SKDAKDKEKL NRHQFAPGTF
661 SGVLQCLVCD KTLLGKESLQ CSNCNANVHK GCKDAAPACT KKFQEKYNKN KPQTILGNSS
721 FRDIPQPGLS LHPSSSVPVG LPTGRRETVG QVHPLSRSVP GTTLESFRRS ATSLESESDH
781 NSCRSRSHSD ELLQSMGSSP STESFIMEDV VDSSLWSDLS SDAQEFEAES WSLVVDPSFC
841 NRQEKDVIKR QDVIFELMQT EMHHIQTLFI MSEIFRKGMK EELQLDHSTV DKIFPCLDEL
901 LEIHRHFFYS MKERRQESCA GSDRNFVIDR IGDILVQQFS EENASKMKKI YGEFCCHHKE
961 AVNLFKELQQ NKKFQNFIKL RNSNLLARRR GIPECILLVT QRITKYPVLV ERILQYTKER
1021 TEEHKDLRKA LCLIKDMIAT VDLKVNEYEK NQKWLEILNK IENKTYTKLK NGHVFRKQAL
1081 MSEERTLLYD GLVYWKTATG RFKDILALLL TDVLLFLQEK DQKYIFAAVD QKPSVISLQK
1141 LIAREVANEE RGMFLISASS AGPEMYEIHT NSKEERNNWM RRIQQAVESC PEEKGGRTSE
1201 SDEDKRKAEA RVAKIQQCQE ILTNQDQQIC AYLEEKLHIY AELGELSGFE DVHLEPHLLI
1261 KPDPGEPPQA ASLLAAALKE AESLQVAVKA SQMGAVSQSC EDSCGDSVLA DTLSSHDVPG
1321 SPTASLVTGG REGRGCSDVD PGIQGVVTDL AVSDAGEKVE CRNFPGSSQS EIIQAIQNLT
1381 RLLYSLQAAL TIQDSHIEIH RLVLQQQEGL SLGHSILRGG PLQDQKSRDA DRQHEELANV
1441 HQLQHQLQQE QRRWLRRCEQ QQRAQATRES WLQERERECQ SQEELLLRSR GELDLQLQEY
1501 QHSLERLREG QRLVEREQAR MRAQQSLLGH WKHGRQRSLP AVLLPGGPEV MELNRSESLC
1561 HENSFFINEA LVQMSFNTFN KLNPSVIHQD ATYPTTQSHS DLVRTSEHQV DLKVDPSQPS
1621 NVSHKLWTAA GSGHQILPFH ESSKDSCKND LDTSHTESPT PHDSNSHRPQ LQAFITEAKL
1681 NLPTRTMTRQ DGETGDGAKE NIVYLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARHGEF28 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- kidney: 30 nTPM
- adrenal gland: 23 nTPM
- stomach: 21 nTPM
- pancreas: 20 nTPM
- ovary: 19 nTPM
- salivary gland: 19 nTPM
Single-cell type
- adrenal cortex cells: 1,082 nCPM
- salivary ionocytes: 592 nCPM
- renal collecting duct intercalated cells: 572 nCPM
- bergmann glia: 550 nCPM
- lacrimal acinar cells: 447 nCPM
- proximal tubule cells: 445 nCPM
Immune cell
- gdT-cell: 0.1 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- NK-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- cerebral cortex: 15 nTPM
- amygdala: 14 nTPM
- hypothalamus: 14 nTPM
- basal ganglia: 14 nTPM
- pons: 12 nTPM
- hippocampal formation: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.73
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell morphogenesis
- central nervous system neuron axonogenesis
- ephrin receptor signaling pathway
- neurofilament cytoskeleton organization
- regulation of Rho protein signal transduction
- regulation of small GTPase mediated signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Dbl homology domain
- Pleckstrin homology domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- PH-like domain superfamily
- Dbl homology (DH) domain superfamily
- ARHGEF1-like, PH domain
- C1-like domain superfamily
- Rho guanine nucleotide exchange factor
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- RhoGEF domain
- PH domain
- ARHGEF28, PH domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARHGEF28 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARHGEF28 as an antibody target. Whether an autoantibody or antibody against ARHGEF28 could matter depends on whether native ARHGEF28 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARHGEF28 is annotated at the cell surface, where native ARHGEF28 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ARHGEF28 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...